Novel small (99m)Tc-labeled affibody molecular probe for PD-L1 receptor imaging

OBJECTIVE: The in vivo imaging of programmed death ligand 1 (PD-L1) can monitor changes in PD-L1 expression and guide programmed death 1 (PD-1) or PD-L1-targeted immune checkpoint therapy. A (99m)Tc-labeled affibody molecular probe targeting the PD-L1 receptor was prepared and evaluated its tracing...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Zhigang, Hu, Xianwen, Hu, Hongyu, Wang, Pan, Cai, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643847/
https://www.ncbi.nlm.nih.gov/pubmed/36387113
http://dx.doi.org/10.3389/fonc.2022.1017737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643847/
https://www.ncbi.nlm.nih.gov/pubmed/36387113
http://dx.doi.org/10.3389/fonc.2022.1017737

Ejemplares similares